Home/Hedge Fund Intelligence/Lakefront Biotherapeutics NV
Nasdaq: LKFTStockForm 13F30 Jun 2026

Hedge funds that hold Lakefront Biotherapeutics NV ADR Nasdaq: LKFT

ADR · CUSIP 36315X101 · who reports it, how much, and how much it matters to them

14 of the 720 hedge fund managers we track reported shares of Lakefront Biotherapeutics NV (Nasdaq: LKFT) on Form 13F for 30 June 2026. Between them they reported USD 211m. The largest position belongs to Madison Avenue Partners, at USD 103m.

Managers reporting it14of 720 we track
Value they reportUSD 211mshares only, 30 Jun 2026
Funds they run261with a file on PPLI.com
Largest positionUSD 103mMadison Avenue Partners
Typical weight0.0%median share of a manager's book
Heaviest weight4.5%Madison Avenue Partners

Compiled from SEC Form 13F filings · Hedge Fund Intelligence, PPLI.com · updated

Form 13F is filed by the manager and covers all of its accounts, so a position here belongs to the firm, not to any one fund. Not investment advice.

13F
What this page is

A list of every manager in our coverage that reported this share at the end of the quarter, taken from the filings themselves. Short positions and options are not in it.

Who holds it

14 managers, USD 211m between them

Taken from each manager's Form 13F for 30 June 2026. A manager appears here if it reported the shares themselves; positions held only through options are left out.

Every manager that reports Lakefront Biotherapeutics NV, largest position first

The bar and the percentage show how much of the manager's reported 13F book the position makes up. Each name opens that manager's largest fund on PPLI.com, where the rest of its book is listed.

#ManagerValue reportedShare of its book
1Madison Avenue Partners1 fund on PPLI.comUSD 103m4.5%
2ECOR1 Capital3 funds on PPLI.comUSD 50m2.4%
3Dme Capital Management7 funds on PPLI.comUSD 14m0.4%
4Renaissance Technologies13 funds on PPLI.comUSD 12m0.0%
5POINT72 Asset Management17 funds on PPLI.comUSD 8.1m0.0%
6D. E. Shaw & Co.15 funds on PPLI.comUSD 5.9m0.0%
7Millennium Management6 funds on PPLI.comUSD 5.4m0.0%
8Dafna Capital Management6 funds on PPLI.comUSD 3.9m0.7%
9Citadel Advisors32 funds on PPLI.comUSD 2.6m0.0%
10Two Sigma Investments35 funds on PPLI.comUSD 2.5m0.0%
11Schonfeld Strategic Advisors30 funds on PPLI.comUSD 977,0000.0%
12Marshall Wace LLP84 funds on PPLI.comUSD 971,0000.0%
13Prelude Capital Management9 funds on PPLI.comUSD 579,0000.0%
14Aquatic Capital Management3 funds on PPLI.comUSD 273,0000.0%
Next: where it matters most
Where it matters most

For Madison Avenue Partners it is 4.5% of the book

A large manager can hold a great deal of a share and barely notice it. This table turns the question round and ranks managers by how much of their own book the position takes up.

#ManagerValue reportedShare of its book
1Madison Avenue PartnersUSD 103m4.5%
2ECOR1 CapitalUSD 50m2.4%
3Dafna Capital ManagementUSD 3.9m0.7%
4Dme Capital ManagementUSD 14m0.4%
5Prelude Capital ManagementUSD 579,0000.0%
6Renaissance TechnologiesUSD 12m0.0%
7POINT72 Asset ManagementUSD 8.1m0.0%
8Aquatic Capital ManagementUSD 273,0000.0%
9Schonfeld Strategic AdvisorsUSD 977,0000.0%
10D. E. Shaw & Co.USD 5.9m0.0%
Next: how to read this
How to read this

What a 13F list can and cannot tell you

  • It is the manager's filing, not a fund's. Form 13F covers every account a firm runs. We cannot say which of its funds holds the shares.
  • It is a snapshot. The list shows the last day of the quarter. A manager may have bought or sold since, and trading inside the quarter leaves no trace.
  • It shows one side. Short positions, swaps and shares listed outside the United States are not reported, so a manager on this list may be hedged or net short.
  • It covers the managers we track. Our coverage is 720 managers of hedge and private funds. Banks, index funds and other institutions that file Form 13F are not counted here.
Next: questions
Questions

Questions about who holds Lakefront Biotherapeutics NV

What is the ticker symbol of Lakefront Biotherapeutics NV?

Lakefront Biotherapeutics NV trades under the symbol LKFT on the Nasdaq. Its CUSIP, the code used on Form 13F, is 36315X101.

Which hedge funds own Lakefront Biotherapeutics NV (Nasdaq: LKFT)?

14 of the 720 hedge fund managers PPLI.com tracks reported Lakefront Biotherapeutics NV shares on Form 13F for 30 June 2026. The largest reported positions were held by Madison Avenue Partners (USD 103m), ECOR1 Capital (USD 50m), Dme Capital Management (USD 14m), Renaissance Technologies (USD 12m) and POINT72 Asset Management (USD 8.1m).

How many hedge funds hold Lakefront Biotherapeutics NV?

14 managers in our coverage reported it, and between them they run 261 funds with a file on PPLI.com. The count is of managers, because Form 13F is filed by the firm and not by each fund.

Which manager has the most riding on Lakefront Biotherapeutics NV?

Madison Avenue Partners, where the position was 4.5% of the reported 13F book at 30 June 2026.

Does this show who is short Lakefront Biotherapeutics NV?

No. Form 13F reports long positions in U.S.-listed shares and options. Short positions are not disclosed in it.

Important information

Positions are taken by PPLI.com from Form 13F filings with the U.S. Securities and Exchange Commission for the quarter shown. They are reported by each manager, cover all of its accounts and may have changed since. PPLI.com has no relationship with Lakefront Biotherapeutics NV or with the managers listed.

Nothing here is investment, tax or legal advice, a recommendation, or an offer or solicitation to buy or sell any security. To report an error, write to the editor.

Private consultation →
Step 1 of 2

Tell us about yourself

Read our Privacy Policy before submitting. Share only the information needed to describe your question; do not include medical records or account credentials.

✦Research assistant
✦PPLI.comResearch assistant
Explore PPLI questions and suitability factors
Ask a general question about PPLI, or explore the factors that affect suitability. Treat the answer as a starting point and check the linked sources.
Use the research with your own tax, legal and insurance advisers.
Preparing an answer
AI assistant. Educational information only. It does not determine eligibility or provide personal tax, legal, investment or insurance advice.